25 November 2020 - Patients with rare diseases are entering ‘random lottery’ draws for clinical trials because Australia is too slow to approve and subsidise new treatments.
Desperate patients with rare diseases are entering “random lottery” draws for clinical trials or begging for donations to pay for new medicines because Australia is too slow to approve and subsidise groundbreaking treatments.